NEW YORK (EGMN) – Findings in 10 key investigative areas, from platelet inhibition and left main coronary artery disease to the use of fractional flow reserves and the “kissing” stent could have a profound impact on interventional cardiology in the next year or so. Dr. Samin K. Sharma, co-director of the Cardiovascular Institute at Mt. Sinai Medical Center in New York, provided his take on these findings at the Mt. Sinai Live Symposium of Complex Coronary and Vascular Cases. They are as...

The following studies were presented at the European Society of Cardiology Annual Congress in Stockholm, on 28 Aug to 1 Sep 2010, and were published online in The Lancet. Heart-rate-lowering drug ivabradine reduces death and hospitalisation when added to standard treatments in patients with heart failure (shift study) Study shows local standards of care affect the benefits of switching to new treatement alternatives Ticagrelor is better than clopidogrel to prevent blood clots...